Literature DB >> 28987544

Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients.

Tae Jun Kim1, Eun Ran Kim1, Sung Noh Hong1, Young-Ho Kim1, Sun-Young Baek2, Soohyun Ahn2, Dong Kyung Chang1.   

Abstract

BACKGROUND AND AIMS: In individuals with either no or 1 to 2 nonadvanced adenomas, future risks of advanced colorectal neoplasia (AN) vary according to clinical risk factors. However, little is known about the association between the adenoma detection rate (ADR) and the risk for metachronous AN in patients with low-risk adenomas.
METHODS: We identified 7171 participants with no or 1 to 2 nonadvanced adenomas at first-time screening colonoscopy. The risk of metachronous AN was investigated at surveillance colonoscopy, according to clinical characteristics and the ADR.
RESULTS: In multivariate analysis the risk for metachronous AN was strongly associated with increasing age, male sex, increasing number of adenomas, and the ADR of the endoscopist. With the ADR modeled as a continuous variable, each 1.0% increase in the rate of ADR predicted a 3.0% decrease in the risk of metachronous AN (adjusted odds ratio [OR], .97; 95% confidence interval [CI], .95-.99). With the ADR modeled using a binary cut-off (32%), the risk of metachronous AN was reduced in patients of endoscopists with an ADR ≥32% (adjusted OR, .53; 95% CI, .35-.83). Moreover, the risk of metachronous AN was reduced (adjusted OR, .66; 95% CI, .46-.95) in patients of endoscopists with an ADR in the highest tertile, compared with patients of endoscopists with ADRs in the lowest tertile. The impact of ADR on metachronous AN was significant for patients with low-risk adenomas rather than patients with no adenoma.
CONCLUSIONS: In patients with low-risk adenomas, the ADR of the endoscopist was inversely associated with the risk of metachronous AN.
Copyright © 2018 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28987544     DOI: 10.1016/j.gie.2017.09.028

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  3 in total

1.  The proof is in the pudding: improving adenoma detection rates reduces interval colon cancer development.

Authors:  Sarah B Umar; Francisco C Ramirez
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-01

2.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

3.  Thinking Big About Small Adenomas: Moving Toward "Precision Surveillance".

Authors:  Thomas F Imperiale
Journal:  Am J Gastroenterol       Date:  2018-10-23       Impact factor: 10.864

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.